ArticleAmerican journal of cancer research2019

HSF1/AMPKα2 mediated alteration of metabolic phenotypes confers increased oxaliplatin resistance in HCC cells.

Jia Hu Shen et al.PubMed ↗Full text ↗

No numbers read from the abstract.